blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1664058

EP1664058 - SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2008
Database last updated on 22.08.2024
Most recent event   Tooltip20.08.2010Lapse of the patent in a contracting state
New state(s): TR		published on 22.09.2010  [2010/38]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[N/P]
Former [2006/23]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / LANG, Hans-Jochen
Rüdesheimer Strasse 7
65719 Hofheim / DE
02 / HEINELT, Uwe
Mosbacher Strasse 54
65187 Wiesbaden / DE
03 / WIRTH, Klaus
Robert-Schumann-Ring 104
65830 Kriftel / DE
04 / LICHER, Thomas
Am Hübenbusch 12
65812 Bad Soden / DE
 [2006/23]
Application number, filing date04764791.203.09.2004
[2006/23]
WO2004EP09836
Priority number, dateDE200314124008.09.2003         Original published format: DE 10341240
[2006/23]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2005026173
Date:24.03.2005
Language:DE
[2005/12]
Type: A1 Application with search report 
No.:EP1664058
Date:07.06.2006
Language:DE
The application published by WIPO in one of the EPO official languages on 24.03.2005 takes the place of the publication of the European patent application.
[2006/23]
Type: B1 Patent specification 
No.:EP1664058
Date:14.11.2007
Language:DE
[2007/46]
Search report(s)International search report - published on:EP24.03.2005
ClassificationIPC:C07D495/04, A61K31/4188, A61P1/00, A61P11/00
[2006/23]
CPC:
C07D495/04 (EP,KR,US); A61K31/4188 (KR); A61P1/00 (EP);
A61P11/00 (EP); A61P13/08 (EP); A61P13/12 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P29/00 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P33/06 (EP); A61P35/00 (EP); A61P7/02 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/23]
Extension statesAL10.04.2006
HR10.04.2006
LT10.04.2006
LV10.04.2006
MK10.04.2006
TitleGerman:SUBSTITUIERTE THIENOIMIDAZOLE, VERFAHREN ZU IHRER HERSTELLUNG, IHRE VERWENDUNG ALS MEDIKAMENT ODER DIAGNOSTIKUM SOWIE SIE ENTHALTENDE MEDIKAMENTE[2007/22]
English:SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME[2006/23]
French:THIENOIMIDAZOLES SUBSTITUES, PROCEDE DE PRODUCTION, UTILISATION COMME MEDICAMENT OU PRODUIT DE DIAGNOSTIC ET MEDICAMENTS CONTENANT CES COMPOSES[2007/22]
Former [2006/23]SUBSTITUIERTE THIENOIMIDAZOLE, VERFAHREN ZU IHRER HERSTELLUNG, IHRE VERWENDUNG ALS MEDIKAMENT ODER DIAGNOSTIKUM SOWIE SIE ENTHALTENDES MEDIKAMENT
Former [2006/23]THIENOIMIDAZOLES SUBSTITUES, PROCEDE DE PRODUCTION, UTILISATION COMME MEDICAMENT OU PRODUIT DE DIAGNOSTIC ET MEDICAMENT CONTENANT CES COMPOSES
Entry into regional phase10.04.2006National basic fee paid 
10.04.2006Designation fee(s) paid 
10.04.2006Examination fee paid 
Examination procedure10.04.2006Examination requested  [2006/23]
21.07.2006Despatch of a communication from the examining division (Time limit: M06)
16.01.2007Reply to a communication from the examining division
18.04.2007Cancellation of oral proceeding that was planned for 23.05.2007
18.04.2007Minutes of oral proceedings despatched
15.05.2007Communication of intention to grant the patent
23.05.2007Date of oral proceedings (cancelled)
25.09.2007Fee for grant paid
25.09.2007Fee for publishing/printing paid
Opposition(s)15.08.2008No opposition filed within time limit [2008/43]
Fees paidRenewal fee
02.10.2006Renewal fee patent year 03
01.10.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY14.11.2007
CZ14.11.2007
DK14.11.2007
EE14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
TR14.11.2007
BG14.02.2008
SE14.02.2008
GR15.02.2008
ES25.02.2008
PT14.04.2008
HU15.05.2008
[2010/38]
Former [2010/34]CY14.11.2007
CZ14.11.2007
DK14.11.2007
EE14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
GR15.02.2008
ES25.02.2008
PT14.04.2008
HU15.05.2008
Former [2009/35]CY14.11.2007
CZ14.11.2007
DK14.11.2007
EE14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
GR15.02.2008
ES25.02.2008
PT14.04.2008
Former [2009/22]CZ14.11.2007
DK14.11.2007
EE14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
GR15.02.2008
ES25.02.2008
PT14.04.2008
Former [2009/13]CZ14.11.2007
DK14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
GR15.02.2008
ES25.02.2008
PT14.04.2008
Former [2008/48]CZ14.11.2007
DK14.11.2007
FI14.11.2007
IE14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
PT14.04.2008
Former [2008/42]CZ14.11.2007
DK14.11.2007
FI14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
PT14.04.2008
Former [2008/39]CZ14.11.2007
DK14.11.2007
FI14.11.2007
NL14.11.2007
PL14.11.2007
RO14.11.2007
SI14.11.2007
SK14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
Former [2008/35]CZ14.11.2007
DK14.11.2007
FI14.11.2007
NL14.11.2007
PL14.11.2007
SI14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
Former [2008/26]FI14.11.2007
NL14.11.2007
PL14.11.2007
SI14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
Former [2008/24]FI14.11.2007
NL14.11.2007
PL14.11.2007
BG14.02.2008
SE14.02.2008
ES25.02.2008
Cited inInternational search[AD]WO0246169  (AVENTIS PHARMA GMBH [DE]) [AD] 1-15 * the whole document *;
 [A]  - JEN T ET AL, "AMIDINES AND RELATED COMPOUNDS. 6 STUDIES ON STRUCTURE-ACTIVITY RELATIONSHIPS OF ANTIHYPERTENSIVE AND ANTISECRETORY AGENTS RELATED TO CLONIDINE", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1975), vol. 18, no. 1, ISSN 0022-2623, pages 90 - 99, XP000567062 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm00235a020
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.